SALT LAKE CITY, UT--(Marketwire - Jan 31, 2013) - ActiveCare, Inc. (OTCBB: ACAR), the service leader in disease and diabetes management today reported through its contract with Colorado Choice Health Plans and TPA that ActiveCare will not only be monitoring diabetics, but hypertension and congestive heart failure members. This contract will add an additional 1,500 to 3,000 new members to ActiveCare's monitoring program. "ActiveCare is excited about our relationship with Colorado Choice, one of the premier third party administrators in the western region," stated Michael Acton, CFO of ActiveCare. "This relationship was instrumental in allowing us to reach our current membership base of approximately 14,000. This contract is also projected to grow significantly over the next twelve months," continued Acton.
Colorado Choice is also optimistic about the relationship with ActiveCare. "Colorado Choice is always looking for ways to deliver the highest quality care to our customers by using leading edge technology," stated Cynthia Palmer, CEO of Colorado Choice. "ActiveCare's unique disease and diabetes management solution provides us with cutting edge disease management technology," continued Ms Palmer. One of the leading factors in the success of ActiveCare's relationship with Colorado Choice is their innovative business model and thought leadership.
ActiveCare, Inc. is the telehealth and personal emergency response solution leader. Headquartered in Salt Lake City, Utah, and publicly traded on the OTC Bulletin Board under symbol ACAR, ActiveCare is committed to providing consistent excellence in quality and safety, and friendly care for members and caregivers alike. To learn more about ActiveCare, Inc., visit the website at www.activecare.com or contact investor/media relations at 877-862-5545 or email@example.com.
About Colorado Choice Health Plans
Colorado Choice Health Plans is a nonprofit organization that has been providing quality, affordable health coverage to Coloradoans for 40 years. The Company has taken a very progressive position in this era of healthcare reform and is currently involved in several pilot programs focused on improving quality of care while reducing costs to consumers. These pilots include an Innovative Benefit Design pilot centered around a new model for shared decision making between patients and their physicians; a bundled episode of care pilot, called Prometheus, focused on putting transparent data into the hands of physicians and tracking improvement on multiple quality measures while sharing savings with providers; and the Comprehensive Primary Care Initiative (CPCi) Pilot which is a CMS Innovation Center pilot striving to support changes in how care is delivered by providing additional funding and transparent data to primary care providers with a goal of improving care outcomes and lowering costs
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.